These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4737130)

  • 1. [2 cases of myasthenia gravis with outstanding effects of massive potassium treatment--evaluation of potassium metabolism].
    Yoshikawa N; Noguchi S; Iguchi H; Morimune S; Nishitani H
    Nihon Rinsho; 1973 Feb; 31(2):401-3. PubMed ID: 4737130
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of exchangeable potassium in myasthenia and in certain other neurological diseases.
    Rowińska K; Kapuściński A
    Pol Med J; 1971; 10(3):750-6. PubMed ID: 4941886
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium metabolism in myasthenia gravis.
    Ozdemir C; Hatemi H; Ozturk EO
    Dis Nerv Syst; 1968 Dec; 29(12):834-6. PubMed ID: 5717297
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of potassium exchange in myasthenia gravis and some other neurological diseases].
    Rowińska K; Kapuściński A
    Neurol Neurochir Pol; 1970; 4(6):633-9. PubMed ID: 4922588
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis.
    Oosterhuis HJ; van der Slooten EP
    J Neurol Sci; 1973 Aug; 19(4):453-60. PubMed ID: 4579659
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of exchangeable electrolyte measurement in the treatment of myasthenia gravis.
    Critchley M; Herman KJ; Harrison M; Shields RA; Liversedge LA
    J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):250-2. PubMed ID: 196049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triaminopteridine in the therapy of myasthenia gravis].
    Mansoldo G; Battocchia A; De Candia O
    Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myasthenia gravis].
    Takamori S
    Naika; 1970 Jun; 25(6):1322-7. PubMed ID: 4914457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of myasthenia with adrencorticotrophins (ACTH and Synacthen). Apropos of 100 treatments in 25 patients].
    Goulon M; Nouailhat F; Barois A; Grosbuis S; Joron MH
    Rev Neurol (Paris); 1972 Oct; 127(4):457-70. PubMed ID: 4355521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cell electrophoretic studies of lymphocytes. 3. Effects of administration of a massive dosage of prednisolone on lymphocyte functions in myasthenia gravis].
    Noguchi S
    Rinsho Shinkeigaku; 1976 May; 16(5):373-80. PubMed ID: 986275
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefit from adrenocorticotrophin in myasthenia gravis.
    Liversedge LA; Yuill GM; Wilkinson IM; Hughes JA
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):412-5. PubMed ID: 4365243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myasthenia gravis: treatment with massive doses of corticosteroids and thymectomy].
    Vidal Secanell JM; Maudes Rodríguez A
    Rev Clin Esp; 1978 Jul; 150(1-2):19-23. PubMed ID: 704988
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical manifestations of myasthenia gravis - review of cases seen at the Lagos University Teaching Hospital.
    Ojini FI; Danesi MA; Ogun SA
    Niger Postgrad Med J; 2004 Sep; 11(3):193-7. PubMed ID: 15505649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocrinologic control of corticoid therapy in myasthenia gravis].
    Tepavcević D; Mikulicić V; Tajić M; Jusić A
    Neurologija; 1979; 27(1-4):181-9. PubMed ID: 262007
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of myasthenia gravis with pancreatic extract].
    Takaoka Y; Takamori M; Ichinose M; Tsujihata M; Ishii N
    Nihon Rinsho; 1973 Feb; 31(2):345-9. PubMed ID: 4737116
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myasthenia gravis--treatment with prednisone].
    Spalek P; Lisý L
    Cesk Neurol Neurochir; 1982 Nov; 45(6):418-24. PubMed ID: 7151207
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary observation of the effect of thymosin on myasthenia gravis].
    Zhang ZX; Ren YL; Tan MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):366-9. PubMed ID: 6241090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of myasthenia gravis with corticosteroids].
    Denislic M; Jereb B; Trontelj JV
    Neurologija; 1978; 26(1-4):55-61. PubMed ID: 754042
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis accompanied with hypokalemic periodic paralysis.
    Sawanyawisuth K; Tiamkao S; Pratipanawatr T
    J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
    Lamartine de Assis J
    Arq Neuropsiquiatr; 1975 Mar; 33(1):33-40. PubMed ID: 1164206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.